Financial
FY2025 revenue $249.3m (-2.0%); operating margin -42.2%; net loss $95.7m.
No debt; $182.3m cash.
Amwell
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Weak
Customer rating
No reviews yet
Financial health
Band: WeakListed: AMWL
FY2025 revenue $249.3m (-2.0%); operating margin -42.2%; net loss $95.7m.
No debt; $182.3m cash.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | US$249.3m | -2.0% | -US$105.3m | -US$95.7m | American Well |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Feb 2026: Amwell guided 2026 revenue to $195–205m, down from $249.3m in 2025, after cutting back products and selling its virtual psychiatric care business; it said it was considering further divestitures of legacy assets.
Cyber & information governance
Sep 2026: A proposed $2.04m class action settlement was reported resolving claims that Amwell's LiveHealth Online booking tool disclosed users' medical information to third parties without permission; Amwell has not admitted wrongdoing. NHS DSPT status not yet checked.
Regulatory & clinical safety
Telehealth platform supplier; no regulatory or clinical safety actions involving Amwell found in HSH's search of the last 24 months.
Contract performance
Aug 2026: The US Defense Health Agency issued an intent to award Amwell a sole-source contract, with terms still under negotiation; DHA had earlier dropped Amwell's behavioural health and automated care programmes from a 2025 extension owing to budget limits.
Competitors
No competitors linked yet.